Last reviewed · How we verify
SODIUM FLUORIDE F 18 — Competitive Intelligence Brief
marketed
Metabolic
Small molecule
Live · refreshed every 30 min
Target snapshot
SODIUM FLUORIDE F 18 (SODIUM FLUORIDE F 18). Sodium Fluoride F 18 is a radioactive compound that accumulates in specific tissues, allowing for imaging of certain bodily functions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SODIUM FLUORIDE F 18 TARGET | SODIUM FLUORIDE F 18 | marketed | 1972-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SODIUM FLUORIDE F 18 CI watch — RSS
- SODIUM FLUORIDE F 18 CI watch — Atom
- SODIUM FLUORIDE F 18 CI watch — JSON
- SODIUM FLUORIDE F 18 alone — RSS
Cite this brief
Drug Landscape (2026). SODIUM FLUORIDE F 18 — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-fluoride-f-18. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab